Francesca Paradiso

7PUBLICATIONS

114CO-AUTHORS

Predictive and prognostic markersMolecular targetsMedical mycologyMicroelectromechanical systems (MEMS)Mechanobiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 04, 2026

Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.

|Mar 26, 2026

Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Aug 12, 2025

CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinoma.

Kathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li

|Jul 08, 2024

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

|Feb 23, 2023

Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.

Gabriele Romano, Francesca Paradiso, Peng Li

|Mar 10, 2022

Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.

Francesca Paradiso, Stefania Lenna, S Andrea Gazze

Pageof 2

Frequent Collaborators

Francesca Taraballi

David S Hong

Jordi Rodon

Anirban Maitra

Shubham Pant

Camila Braganca Xavier

Paola A Guerrero

Kate Murphy

Peng Li

Pooja Shukla

Frequent Collaborators

Francesca Taraballi

David S Hong

Jordi Rodon

Anirban Maitra